YY/T 1874-2023 Active Industry standards-Medicine

YY/T 1874-2023 Active implantable medical devices—Electromagnetic compatibility—EMC test protocols for implantable cardiac pacemakers,implantable cardioverter defibrillators and cardiac resynchronization devices

YY/T 1874-2023 Active implantable medical devices—Electromagnetic compatibility—EMC test protocols for implantable cardiac pacemakers,implantable cardioverter defibrillators and cardiac resynchronization devices

Publish Date: 2023-03-14 Implement Date: 2024-05-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 228
Download

Basic Information

Standard Code: YY/T 1874-2023
Standard Type: Industry standards
Standard Status: Active
is_force_gb: no
CCS Name: Orthopaedic surgery, orthopaedic instruments
ICS Name: Surgical implants, prostheses, and orthoses
Publish Date: 2023-03-14
Implement Date: 2024-05-01
Pages: 123 pages

Scope

This document specifies the electromagnetic compatibility (EMC) test methods for active implantable cardiovascular devices used to evaluate the treatment of bradycardia, tachycardia, and cardiac resynchronization, which can be provided with a venous electrode lead system.
Note: This document is designed for use with pulse generators that are compatible with endocardial or epicardial electrode leads. For pulse generators that do not use endocardial or epicardial electrode lead technology, manufacturers using these technologies can adjust them as needed.
This document specifies the performance limits of such devices when they interact with EM transmitters that can operate within the following two EM spectrum ranges:
—— 0 Hz≤f<385 MHz;
—— 385 MHz≤f≤3,000 MHz.
This document also specifies the requirements for protecting such devices from the effects of EM fields in medical environments, defines the required accompanying documents, and provides information about the EM transmitter manufacturer and the expected immunity level.
This document applies to active implantable cardiovascular devices that can be provided with a venous electrode lead system for one or more treatments of bradycardia, tachycardia, and cardiac resynchronization.

Development Information

Word Count: 240 Thousand words Pages: 123 pages

Referenced Standards

ISO 14708-1:2014 ISO 14708-2:2019 ISO 14708-6:2019

Adopt standards

ISO 14117:2019

Related Standards

Contact Us